OptimizeRx Corporation (NASDAQ:OPRX) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants William Febbo – Chief Executive Officer Ed Stelmakh – Chief Financial Officer Stephen Silvestro – Chief Commercial Officer Andrew D’Silva – Senior Vice President of Corporate Finance Conference Call Participants Jared Haase – William Blair Sean Dodge – RBC Capital Markets Eric Martinuzzi – Lake Street Marc Wiesenberger – B. Riley Securities Operator Good afternoon, and thank you for joining ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Commission File Number: 001-38543 OptimizeRx Corporation (Exact name of registrant as specified in its charter) Nevada 26-1265381 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2021 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ________ to __________ (State or other jurisd ...

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2021 Results Conference Call August 4, 2021 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Doug Baker - Chief Financial Officer Stephen Silvestro - Chief Commercial Officer Conference Call Participants Ryan Daniels - William Blair Sean Dodge - RBC Capital Markets Andrew D'Silva - B. Riley Securities Eric Martinuzzi - Lake Street Capital Harvey Poppel - Poptech, LP Operator Good afternoon and thank you for joining OptimizeRx Corporation's Secon ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ________ to __________ Commission File Number: 001-38543 OptimizeRx Corporation (Exact name of registrant as specified in its charter) Nevada 26-1265381 (State or other jurisdiction o ...

NASDAQ:OPRX A Digital Health Platform Corporate Presentation May 2021 Physician Communications Patient Engagement Adherence © Copyright OptimizeRx, Inc. 2021 & 2020. All rights reserved NASDAQ : OPRX Important Cautions Regarding Forward Looking Statements This presentation has been prepared by OptimizeRx Corporation ("w e," "us," "our," "OptimizeRx" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shal ...

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Doug Baker - Chief Financial Officer Stephen Silvestro - Chief Commercial Officer Miriam Paramore - President Conference Call Participants Ryan Daniels - William Blair Andrew D'Silva - B. Riley Securities FBR Sean Dodge - RBC Capital Markets Eric Martinuzzi - Lake Street Harvey Poppel - Poptech, LP Alex Silverman - AWM Investments Operator Good afternoon. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2021 ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission File Number: 001-38543 OptimizeRx Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ________ Commission file number: 001-38543 OptimizeRx Corporation (Exact name of registrant as specified in its charter) | Nevada | 26-1265381 | | --- | --- | | (State or other ...

OptimizeRx Corporation. (NASDAQ:OPRX) Q4 2020 Results Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Doug Baker - Chief Financial Officer Stephen Silvestro - Chief Commercial Officer Miriam Paramore - President Conference Call Participants Ryan Daniels - William Blair Andrew D'Silva - B. Riley Securities Eric Martinuzzi - Lake Street Harvey Poppel - Poptech, LP Siddharth Kapoor - Silver Mount Capital. Operator Good afternoon, and thank you ...

NASDAQ:OPRX A Digital Health Platform Corporate Presentation November 2020 Physician Communications Patient Engagement Adherence © Copyright OptimizeRx, Inc. 2020 & 2019. All rights reserved NASDAQ : OPRX Important Cautions Regarding Forward Looking Statements This presentation has been prepared by OptimizeRx Corporation ("we," "us," "our," "OptimizeRx" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor ...